Vyšlo v časopise: Čes-slov Pediat 2016; 71 (1): 39-43.
Kategorie: Doporučené postupy

  1. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49: 498–547.
  2. Lightdale JR, Gremse DA. Gastroesophageal reflux: management guidance for the pediatrician. Pediatrics 2013; 131: e1684–e1695.
  3. Mastronarde JG, Anthonisen NR, Castro M, et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 2009; 360: 1487–1499.
  4. Blake K, Teague WG. Gastroesophageal reflux disease and childhood asthma. Curr Opin Pulm Med 2013; 19: 24–29.
  5. Ghezzi M, Silvestri M, Guida E, et al. Acid and weakly acid gastroesophageal refluxes and type of respiratory symptoms in children. Respir Med 2011; 105: 972–978.
  6. Piccione JC, McPhail GL, Fenchel MC, et al. Bronchiectasis in chronic pulmonary aspiration: risk factors and clinical implications. Pediatr Pulmonol 2012; 47: 447–452.
  7. Khoshoo V, Mohnot S, Haydel R Jr, et al. Bronchial hyperreactivity in non-atopic children with asthma and reflux: effect of anti-reflux treatment. Pediatr Pulmonol 2009; 44: 1070–1074.
  8. Rothenberg S, Cowles R. The effects of laparoscopic Nissen fundoplication on patients with severe gastroesophageal reflux disease and steroid-dependent asthma. J Pediatr Surg 2012; 47: 1101–1104.
  9. Beyer JE, McGrath PJ, Berde CB. Discordance between self-report and behavioral pain measures in children aged 3-7 years after surgery. J Pain Symptom Manage 1990; 5: 350–356.
  10. Koufman JA. The otolaryngologic manifestations of gastroesophageal reflux disease (GERD): a clinical investigation of 225 patients using ambulatory 24-hour pH monitoring and an experimental investigation of the role of acid and pepsin in the development of laryngeal injury. Laryngoscope 1991; 101: 1–78.
  11. Ossakow SJ, Elta G, Colturi T, et al. Esophageal reflux and dysmotility as the basis for persistent cervical symptoms. Ann Otol Rhinol Laryngol 1987; 96: 387–392.
  12. Wiener GJ, Koufman JA, Wu WC, et al. Chronic hoarseness secondary to gastroesophageal reflux disease: documentation with 24-h ambulatory pH monitoring. Am J Gastroenterol 1989; 84: 1503–1508.
  13. Belafsky PC, Postma GN, Koufman JA. The validity and reliability of the reflux finding score (RFS). Laryngoscope 2001; 111: 1313–1317.
  14. Belafsky PC, Postma GN, Amin MR, et al. Symptoms and findings of laryngopharyngeal reflux. Ear Nose Throat J 2002; 81: 10–13.
  15. Ylitalo R, Baugh A, Li W, et al. Effect of acid and pepsin on gene expression in laryngeal fibroblasts. Ann Otol Rhinol Laryngol 2004; 113: 866–871.
  16. Del Buono R, Wenzl TG, Rawat D, et al. Acid and nonacid gastro-oesophageal reflux in neurologically impaired children: investigation with the multiple intraluminal impedance procedure. J Pediatr Gastroenterol Nutr 2006; 43: 331–335.
  17. Johnston N, Bulmer D, Gill GA, et al. Cell biology of laryngeal epithelial defenses in health and disease: further studies. Ann Otol Rhinol Laryngol 2003; 112: 481–491.
  18. Koufman JA. Laryngopharyngeal reflux 2002: a new paradigm of airway disease. Ear Nose Throat J 2002; 81: 2–6.
  19. Little FB, Koufman JA, Kohut RI, et al. Effect of gastric acid on the pathogenesis of subglottic stenosis. Ann Otol Rhinol Laryngol 1985; 94: 516–519.
  20. Postma GN, Belafsky PC, Aviv JE, et al. Laryngopharyngeal reflux testing. Ear Nose Throat J 2002; 81: 14–18.
  21. Smit CF, van Leeuwen JA, Mathus-Vliegen LM, et al. Gastropharyngeal and gastroesophageal reflux in globus and hoarseness. Arch Otolaryngol Head Neck Surg 2000; 126: 827–830.
  22. Vincent DA, Jr., Garrett JD, Radionoff SL, et al. The proximal probe in esophageal pH monitoring: development of a normative database. J Voice 2000; 14: 247–254.
  23. Smit CF, Tan J, Devriese PP, et al. Ambulatory pH measurements at the upper esophageal sphincter. Laryngoscope 1998; 108: 299–302.
  24. Quitadamo P, Di Nardo G, Miele E, et al. Gastro-esophageal reflux in young children and adolescents: Is there a relationship between symptom severity and esophageal histological grade? J Pediatr Gastroenterol Nutr 2015; 60: 318–321.
  25. Corrado G, Fossati C, Turchetti A, et al. Irritable oesophagus: a new cause of Sandifer‘s syndrome. Acta Paediatr 2006; 95: 1509–1510.
  26. Frankel EA, Shalaby TM, Orenstein SR. Sandifer syndrome posturing: relation to abdominal wall contractions, gastroesophageal reflux, and fundoplication. Dig Dis Sci 2006; 51: 635–640.
  27. Cerimagic D, Ivkic G, Bilic E. Neuroanatomical basis of Sandifer‘s syndrome: a new vagal reflex? Med Hypotheses 2008; 70: 957–961.
  28. Puntis JW, Smith HL, Buick RG, et al. Effect of dystonic movements on oesophageal peristalsis in Sandifer‘s syndrome. Arch Dis Child 1989; 64: 1311–1313.
  29. Tipnis NA, Tipnis SM. Controversies in the treatment of gastroesophageal reflux disease in preterm infants. Clin Perinatol 2009; 36: 153–164.
  30. Birch JL, Newell SJ. Gastrooesophageal reflux disease in preterm infants: current management and diagnostic dilemmas. Arch Dis Child Fetal Neonatal Ed 2009; 94: F379–83.
  31. van der Pol R, Smite M, Benninga MA, et al. Non-pharmacological therapies for GERD in infants and children. J Pediatr Gastroenterol Nutr 2011; 53 (Suppl 2): S6–8.
  32. van Wijk MP, Benninga MA, Dent J, et al. Effect of body position changes on postprandial gastroesophageal reflux and gastric emptying in the healthy premature neonate. J Pediatr 2007; 151: 585-90, 90 e1–2.
  33. Fennerty MB. Use of antisecretory agents as a trial of therapy. Gut 2002; 50 (Suppl 4): iv63–66.
  34. Fass R, Fennerty MB, Ofman JJ, et al. The clinical and economic value of a short course of omeprazole in patients with noncardiac chest pain. Gastroenterology 1998; 115: 42–49.
  35. Wenzl TG, Benninga MA, Loots CM, et al. Indications, methodology, and interpretation of combined esophageal impedance-pH monitoring in children: ESPGHAN EURO-PIG standard protocol. J Pediatr Gastroenterol Nutr 2012; 55: 230–234.
  36. Pilic D, Frohlich T, Noh F, et al. Detection of gastroesophageal reflux in children using combined multichannel intraluminal impedance and pH measurement: data from the German Pediatric Impedance Group. J Pediatr 2011; 158: 650–654 e1.
  37. Vandenplas Y. Management of paediatric GERD. Nat Rev Gastroenterol Hepatol 2014; 11: 147–157.
  38. Vandenplas Y, Goyvaerts H, Helven R, et al. Gastroesophageal reflux, as measured by 24-hour pH monitoring, in 509 healthy infants screened for risk of sudden infant death syndrome. Pediatrics 1991; 88: 834–840.
  39. Wenzl TG, Moroder C, Trachterna M, et al. Esophageal pH monitoring and impedance measurement: a comparison of two diagnostic tests for gastroesophageal reflux. J Pediatr Gastroenterol Nutr 2002; 34: 519–523.
  40. Wenzl TG. Role of diagnostic tests in GERD. J Pediatr Gastroenterol Nutr 2011; 53 (Suppl 2): S4–6.
  41. Turk H, Hauser B, Brecelj J, et al. Effect of proton pump inhibition on acid, weakly acid and weakly alkaline gastro-esophageal reflux in children. World J Pediatr 2013; 9: 36–41.
  42. Hassall E. Uses and abuses of acid-suppression therapy in children. J Pediatr Gastroenterol Nutr 2011; 53 (Suppl 2): S8–9.
  43. Blondeau K, Mertens V, Dupont L, et al. The relationship between gastroesophageal reflux and cough in children with chronic unexplained cough using combined impedance-pH-manometry recordings. Pediatr Pulmonol 2011; 46: 286–294.
  44. Farre R, Blondeau K, Clement D, et al. Evaluation of oesophageal mucosa integrity by the intraluminal impedance technique. Gut 2011; 60: 885–892.
  45. Ummarino D, Salvatore S, Hauser B, et al. Baseline esophageal impedance according to different time intervals. Dis Esophagus 2013; 26: 582–526.
  46. Salvatore S, Salvatoni A, Van Steen K, et al. Behind the (impedance) baseline in children. Dis Esophagus 2014; 27: 726–731.
  47. Corvaglia L, Zama D, Gualdi S, et al. Gastro-oesophageal reflux increases the number of apnoeas in very preterm infants. Arch Dis Child Fetal Neonatal Ed 2009; 94: F188–192.
  48. Gullung JL, Hill EG, Castell DO, et al. Oropharyngeal and esophageal swallowing impairments: their association and the predictive value of the modified barium swallow impairment profile and combined multichannel intraluminal impedance-esophageal manometry. Ann Otol Rhinol Laryngol 2012; 121: 738–745.
  49. Strobel CT, Byrne WJ, Ament ME, et al. Correlation of esophageal lengths in children with height: application to the Tuttle test without prior esophageal manometry. J Pediatr 1979; 94: 81–84.
  50. Pilic D, Hofs C, Weitmann S, et al. Inter- and intraobserver agreement in 24-hour combined multiple intraluminal impedance and pH measurement in children. J Pediatr Gastroenterol Nutr 2011; 53: 255–259.
  51. Loots CM, van Wijk MP, Blondeau K, et al. Interobserver and intraobserver variability in pH-impedance analysis between 10 experts and automated analysis. J Pediatr 2012; 160: 441–446 e1.
  52. Omari TI, Schwarzer A, vanWijk MP, et al. Optimisation of the reflux-symptom association statistics for use in infants being investigated by 24-hour pH impedance. J Pediatr Gastroenterol Nutr 2011; 52: 408–413.
  53. Weusten BL, Roelofs JM, Akkermans LM, et al. The symptom-association probability: an improved method for symptom analysis of 24-hour esophageal pH data. Gastroenterology 1994; 107: 1741–1745.
  54. Katra R, Kabelka Z, Jurovcik M, et al. Pilot study: Association between Helicobacter pylori in adenoid hyperplasia and reflux episodes detected by multiple intraluminal impedance in children. Int J Pediatr Otorhinolaryngol 2014; 78: 1243–1249.
  55. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 190–200.
  56. Hassall E. Decisions in diagnosing and managing chronic gastroesophageal reflux disease in children. J Pediatr 2005; 146: S3–12.
  57. Kahrilas PJ, Pandolfino JE. Review article: oesophageal pH monitoring – technologies, interpretation and correlation with clinical outcomes. Aliment Pharmacol Ther 2005; 22 (Suppl 3): 2–9.
  58. Lichtenstein DR, Cash BD, Davila R, et al. Role of endoscopy in the management of GERD. Gastrointest Endosc 2007; 66: 219–224.
  59. Vakil N, van Zanten SV, Kahrilas P, et al. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol 2006; 101: 1900–1920; quiz 43.
  60. Ronkainen J, Aro P, Storskrubb T, et al. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report. Scand J Gastroenterol 2005; 40: 275–285.
  61. Sherman PM, Hassall E, Fagundes-Neto U, et al. A global, evidence-based consensus on the definition of gastroesophageal reflux disease in the pediatric population. Am J Gastroenterol 2009; 104: 1278–1295; quiz 96.
  62. Martin AJ, Pratt N, Kennedy JD, et al. Natural history and familial relationships of infant spilling to 9 years of age. Pediatrics 2002; 109: 1061–1067.
  63. Sharaf RN, Shergill AK, Odze RD, et al. Endoscopic mucosal tissue sampling. Gastrointest Endosc 2013; 78: 216–224.
  64. Jeurnink SM, van Herwaarden-Lindeboom MY, Siersema PD, et al. Barrett‘s esophagus in children: does it need more attention? Dig Liver Dis 2011; 43: 682–687.
  65. Lundell LR, Dent J, Bennett JR, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut 1999; 45: 172–180.
  66. Armstrong D, Emde C, Inauen W, et al. Diagnostic assessment of gastroesophageal reflux disease: what is possible vs. what is practical? Hepatogastroenterology 1992; 39 (Suppl 1): 3–13.
  67. Armstrong D. Endoscopic evaluation of gastro-esophageal reflux disease. Yale J Biol Med 1999; 72: 93–100.
  68. Rosen R, Amirault J, Johnston N, et al. The utility of endoscopy and multichannel intraluminal impedance testing in children with cough and wheezing. Pediatr Pulmonol 2014; 49: 1090–1096.
  69. Najada AS, Dahabreh MM. Bronchoscopy findings in children with recurrent and chronic stridor. J Bronchology Interv Pulmonol 2011; 18: 42–47.
  70. Bibi H, Khvolis E, Shoseyov D, et al. The prevalence of gastroesophageal reflux in children with tracheomalacia and laryngomalacia. Chest 2001; 119: 409–413.
  71. Carr MM, Nagy ML, Pizzuto MP, et al. Correlation of findings at direct laryngoscopy and bronchoscopy with gastroesophageal reflux disease in children: a prospective study. Arch Otolaryngol Head Neck Surg 2001; 127: 369–374.
  72. Ahrens P, Noll C, Kitz R, et al. Lipid-laden alveolar macrophages (LLAM): a useful marker of silent aspiration in children. Pediatr Pulmonol 1999; 28: 83–88.
  73. Rosen R, Fritz J, Nurko A, et al. Lipid-laden macrophage index is not an indicator of gastroesophageal reflux-related respiratory disease in children. Pediatrics 2008; 121: e879–884.
  74. Kelly EA, Parakininkas DE, Werlin SL, et al. Prevalence of pediatric aspiration-associated extraesophageal reflux disease. JAMA Otolaryngol Head Neck Surg 2013; 139: 996–1001.
  75. Farrell S, McMaster C, Gibson D, et al. Pepsin in bronchoalveolar lavage fluid: a specific and sensitive method of diagnosing gastro-oesophageal reflux-related pulmonary aspiration. J Pediatr Surg 2006; 41: 289–293.
  76. Starosta V, Kitz R, Hartl D, et al. Bronchoalveolar pepsin, bile acids, oxidation, and inflammation in children with gastroesophageal reflux disease. Chest 2007; 132: 1557–1564.
  77. McNally P, Ervine E, Shields MD, et al. High concentrations of pepsin in bronchoalveolar lavage fluid from children with cystic fibrosis are associated with high interleukin-8 concentrations. Thorax 2011; 66: 140–143.
  78. Rosen R, Johnston N, Hart K, et al. The presence of pepsin in the lung and its relationship to pathologic gastro-esophageal reflux. Neurogastroenterol Motil 2012; 24: 129–133, e84–85.
  79. Lommatzsch SE, Martin RJ, Good JT Jr. Importance of fiberoptic bronchoscopy in identifying asthma phenotypes to direct personalized therapy. Curr Opin Pulm Med 2013; 19: 42–48.
  80. Sacco O, Silvestri M, Sabatini F, et al. IL-8 and airway neutrophilia in children with gastroesophageal reflux and asthma-like symptoms. Respir Med 2006; 100: 307–315.
  81. Belafsky PC, Postma GN, Koufman JA. Validity and reliability of the reflux symptom index (RSI). J Voice 2002; 16: 274–277.
  82. Stephen TC, Younoszai MK, Massey MP, et al. Diagnosis of gastroesophageal reflux in pediatrics. J Ky Med Assoc 1994; 92: 188–191.
  83. Thompson JK, Koehler RE, Richter JE. Detection of gastroesophageal reflux: value of barium studies compared with 24-hr pH monitoring. AJR Am J Roentgenol 1994; 162: 621–626.
  84. Gupta JP, Kumar A, Jain AK, et al. Gastro-esophageal reflux disease (GERD): an appraisal of different tests for diagnosis. J Assoc Physicians India 1990; 38 (Suppl 1): 699–702.
  85. Chen MY, Ott DJ, Sinclair JW, et al. Gastroesophageal reflux disease: correlation of esophageal pH testing and radiographic findings. Radiology 1992; 185: 483–486.
  86. Seibert JJ, Byrne WJ, Euler AR, et al. Gastroesophageal reflux - the acid test: scintigraphy or the pH probe? AJR Am J Roentgenol 1983; 140: 1087–1090.
  87. Arasu TS, Wyllie R, Fitzgerald JF, et al. Gastroesophageal reflux in infants and children comparative accuracy of diagnostic methods. J Pediatr 1980; 96: 798–803.
  88. Kahrilas PJ, Shaheen NJ, Vaezi MF, et al. American Gastroenterological Association Medical Position Statement on the management of gastroesophageal reflux disease. Gastroenterology 2008; 135: 1383–1391, 91 e1–5.
  89. Kawahara H, Dent J, Davidson G. Mechanisms responsible for gastroesophageal reflux in children. Gastroenterology 1997; 113: 399–408.
  90. Mattioli G, Sacco O, Repetto P, et al. Necessity for surgery in children with gastrooesophageal reflux and supraoesophageal symptoms. Eur J Pediatr Surg 2004; 14: 7–13.
  91. Saritas Yuksel E, Hong SK, Strugala V, et al. Rapid salivary pepsin test: blinded assessment of test performance in gastroesophageal reflux disease. Laryngoscope 2012; 122: 1312–1316.
  92. Hayat JO, Gabieta-Somnez S, Yazaki E, et al. Pepsin in saliva for the diagnosis of gastro-oesophageal reflux disease. Gut 2015; 64: 373–380.
  93. Ward RM, Kearns GL. Proton pump inhibitors in pediatrics : mechanism of action, pharmacokinetics, pharmacogenetics, and pharmacodynamics. Paediatr Drugs 2013; 15: 119–131.
  94. Holbrook JT, Wise RA, Gold BD, et al. Lansoprazole for children with poorly controlled asthma: a randomized controlled trial. JAMA 2012; 307: 373–381.
  95. Hassall E, Owen D, Kerr W, et al. Gastric histology in children treated with proton pump inhibitors long term, with emphasis on enterochromaffin cell-like hyperplasia. Aliment Pharmacol Ther 2011; 33: 829–836.
  96. Tjon JA, Pe M, Soscia J, et al. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease. Pharmacotherapy 2013; 33: 956–971.
  97. Beall DP, Henslee HB, Webb HR, et al. Milk-alkali syndrome: a historical review and description of the modern version of the syndrome. Am J Med Sci 2006; 331: 233–242.
  98. Maclennan S, Augood C, Cash-Gibson L, et al. Cisapride treatment for gastro-oesophageal reflux in children. Cochrane Database Syst Rev 2010; CD002300.
  99. Pritchard TS. Should domperidone be used for the treatment of gastro-oesophageal reflux in children? Systematic review of randomized controlled trials in children aged 1 month to 11 years old. Br J Clin Pharmacol 2005; 59: 725–729.
  100. Tighe MP, Afzal NA, Bevan, A et al. Current pharmacological management of gastro-esophageal reflux in children: an evidence-based systematic review. Paediatr Drugs 2009; 11: 185–202.
  101. Perrio M, Voss S, Shakir SA. Application of the bradford hill criteria to assess the causality of cisapride-induced arrhythmia: a model for assessing causal association in pharmacovigilance. Drug Saf 2007; 30: 333–346.
  102. Ciccaglione AF, Marzio L. Effect of acute and chronic administration of the GABA B agonist baclofen on 24 hour pH metry and symptoms in control subjects and in patients with gastro-oesophageal reflux disease. Gut 2003; 52: 464–470.
  103. Poynard T, Vernisse B, Agostini H. Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux. Aliment Pharmacol Ther 1998; 12: 159–165.
  104. Greally P, Hampton FJ, MacFadyen UM, et al. Gaviscon and Carobel compared with cisapride in gastro-oesophageal reflux. Arch Dis Child 1992; 67: 618–621.
  105. Buts JP, Barudi C, Otte JB. Double-blind controlled study on the efficacy of sodium alginate (Gaviscon) in reducing gastroesophageal reflux assessed by 24 h continuous pH monitoring in infants and children. Eur J Pediatr 1987; 146: 156–158.
  106. Forbes D, Hodgson M, Hill R. The effects of gaviscon and metoclopramide in gastroesophageal reflux in children. J Pediatr Gastroenterol Nutr 1986; 5: 556–559.
  107. Tighe M, Afzal NA, Bevan A, et al. Pharmacological treatment of children with gastro-oesophageal reflux. Cochrane Database Syst Rev 2014; 11: CD008550.
  108. Arguelles-Martin F, Gonzalez-Fernandez F, Gentles MG. Sucralfate versus cimetidine in the treatment of reflux esophagitis in children. Am J Med 1989; 86: 73–76.
  109. van der Pol R, Smite M, Benninga MA, et al. Non-pharmacological therapies for GERD in infants and children. J Pediatr Gastroenterol Nutr 53 (Suppl 2): S6–8.
  110. Horvath A, Dziechciarz P, Szajewska H. The effect of thickened-feed interventions on gastroesophageal reflux in infants: systematic review and meta-analysis of randomized, controlled trials. Pediatrics 2008; 122: e1268–1277.
  111. Salvatore S, Vandenplas Y. Gastroesophageal reflux and cow milk allergy: is there a link? Pediatrics 2002; 110: 972–984.
  112. Alaswad B, Toubas PL, Grunow JE. Environmental tobacco smoke exposure and gastroesophageal reflux in infants with apparent life-threatening events. J Okla State Med Assoc 1996; 89: 233–237.
  113. Jacobson BC, Somers SC, Fuchs CS, et al. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006; 354: 2340–2348.
  114. Whiteman DC, Sadeghi S, Pandeya N, et al. Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 2008; 57: 173–180.
  115. Piesman M, Hwang I, Maydonovitch C, et al. Nocturnal reflux episodes following the administration of a standardized meal. Does timing matter? Am J Gastroenterol 2007; 102: 2128–2134.
  116. Antunes EB, Lunet N. Effects of the head lift exercise on the swallow function: a systematic review. Gerodontology 2012; 29: 247–257.
  117. Carvalho de Miranda Chaves R, Suesada M, Polisel F, et al. Respiratory physiotherapy can increase lower esophageal sphincter pressure in GERD patients. Respir Med 106: 1794–1799.
  118. Šnajdauf J, Škába R. Dětská chirurgie. Praha: Galén; 2005.
  119. Pearson EG, Downey EC, Barnhart DC, et al. Reflux esophageal stricture--a review of 30 years‘ experience in children. J Pediatr Surg 2010; 45: 2356–2360.
  120. Struijs MC, Lasko D, Somme S, et al. Gastric emptying scans: unnecessary preoperative testing for fundoplications? J Pediatr Surg 2010; 45: 350–354; discussion 4.
  121. Guner YS, Elliott S, Marr CC, et al. Anterior fundoplication at the time of congenital diaphragmatic hernia repair. Pediatr Surg Int 2009; 25: 715–718.
  122. Tannuri AC, Tannuri U, Mathias AL, et al. Gastroesophageal reflux disease in children: efficacy of Nissen fundoplication in treating digestive and respiratory symptoms. Experience of a single center. Dis Esophagus 2008; 21: 746–750.
  123. Mauritz FA, Blomberg BA, Stellato RK, et al. Complete versus partial fundoplication in children with gastroesophageal reflux disease: results of a systematic review and meta-analysis. J Gastrointest Surg 2013; 17: 1883–1892.
  124. Viswanath N, Wong D, Channappa D, et al. Is prophylactic fundoplication necessary in neurologically impaired children? Eur J Pediatr Surg 2010; 20: 226–229.
  125. Kane TD. Laparoscopic Nissen fundoplication. Minerva Chir 2009; 64: 147–157.
  126. Diaz DM, Gibbons TE, Heiss K, et al. Antireflux surgery outcomes in pediatric gastroesophageal reflux disease. Am J Gastroenterol 2005; 100: 1844–1852.
  127. Pacilli M, Eaton S, McHoney M, et al. Four year follow-up of a randomised controlled trial comparing open and laparoscopic Nissen fundoplication in children. Arch Dis Child 2014; 99: 516–521.
  128. Martin K, Deshaies C, Emil S. Outcomes of pediatric laparoscopic fundoplication: a critical review of the literature. Can J Gastroenterol Hepatol 2014; 28: 97–102.
  129. Lopez-Fernandez S, Hernandez F, Hernandez-Martin S, et al. Failed Nissen fundoplication in children: causes and management. Eur J Pediatr Surg 2014; 24: 79–82.
  130. Gilger MA, Yeh C, Chiang J, et al. Outcomes of surgical fundoplication in children. Clin Gastroenterol Hepatol 2004; 2: 978–984.
  131. Kubiak R, Spitz L, Kiely EM, et al. Effectiveness of fundoplication in early infancy. J Pediatr Surg 1999; 34: 295–299.
  132. Mauritz FA, van Herwaarden-Lindeboom MY, Zwaveling S, et al. Laparoscopic Thal fundoplication in children: a prospective 10- to 15-year follow-up study. Ann Surg 2014; 259: 388–393.
  133. Randolph JG. Y-U advancement pyloroplasty. Ann Surg 1975; 181: 586–590.
  134. van der Zee DC, Arends NJ, Bax NM. The value of 24-h pH study in evaluating the results of laparoscopic antireflux surgery in children. Surg Endosc 1999; 13: 918–921.
  135. Sullivan PB. Gastrointestinal disorders in children with neurodevelopmental disabilities. Dev Disabil Res Rev 2008; 14: 128–136.
  136. Wesley JR, Coran AG, Sarahan TM, et al. The need for evaluation of gastroesophageal reflux in brain-damaged children referred for feeding gastrostomy. J Pediatr Surg 1981; 16: 866–871.
  137. Reyes AL, Cash AJ, Green SH, et al. Gastrooesophageal reflux in children with cerebral palsy. Child: Care, Health & Development 1993; 19: 109–118.
  138. Gustafsson PM, Tibbling L. Gastro-oesophageal reflux and oesophageal dysfunction in children and adolescents with brain damage. Acta Paediatr 1994; 83: 1081–1085.
  139. Del Giudice E, Staiano A, Capano G, et al. Gastrointestinal manifestations in children with cerebral palsy. Brain Dev 1999; 21: 307–11.
  140. Macchini F, Leva E, Torricelli M, et al. Treating acid reflux disease in patients with Down syndrome: pharmacological and physiological approaches. Clin Exp Gastroenterol 2011; 4: 19–22.
  141. Luzzani S, Macchini F, Valadè A, et al. Gastroesophageal reflux and Cornelia de Lange syndrome: Typical and atypical symptoms. Am J Med Genet Part A 2003; 119A: 283–287.
  142. Staiano A, Cucchiara S, Del Giudice E, et al. Disorders of oesophageal motility in children with psychomotor retardation and gastro-oesophageal reflux. Eur J Pediatr 1991; 150: 638–641.
  143. Pensabene L, Miele E, Giudice ED, et al. Mechanisms of gastroesophageal reflux in children with sequelae of birth asphyxia. Brain Dev 2008; 30: 563–571.
  144. Halpern LM, Jolley SG, Johnson DG. Gastroesophageal reflux: A significant association with central nervous system disease in children. J Pediatr Surg 1991; 26: 171–183.
  145. Harrington JW, Brand DA, Edwards KS. Seizure disorder as a risk factor for gastroesophageal reflux in children with neurodevelopmental disabilities. Clinical Pediatrics 2004; 43: 557–562.
  146. Böhmer C, Niezen-de Boer M, Klinkenberg-Knol E, et al. Gastro-oesophageal reflux disease in institutionalised intellectually disabled individuals. Neth J Med 1997; 51: 134–139.
  147. Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer RC, et al. The prevalence of gastroesophageal reflux disease based on non-specific symptoms in institutionalized, intellectually disabled individuals. Eur J Gastroenterol Hepatol 1997; 9: 187–190.
  148. Böhmer CJ, Klinkenberg-Knol EC, Niezen-de Boer MC, et al. Gastroesophageal reflux disease in intellectually disabled individuals: how often, how serious, how manageable? Am J Gastroenterol 2000; 95: 1868–1872.
  149. Böhmer C, Niezen-de Boer M, Klinkenberg-Knol E, et al. The prevalence of gastroesophageal reflux disease in institutionalized intellectually disabled individuals. Am J Gastroenterol 1999; 94: 804–810.
  150. Vandenplas Y, Rudolph CD, Di Lorenzo C, et al. Pediatric gastroesophageal reflux clinical practice guidelines: joint recommendations of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN). J Pediatr Gastroenterol Nutr 2009; 49: 498–547.
  151. Gössler A, Schalamon J, Huber-Zeyringer A, et al. Gastroesophageal reflux and behavior in neurologically impaired children. J Pediatr Surg 2007; 42: 1486–1490.
  152. Coghlan JA, Forbes A, Bell SN, et al. Efficacy and safety of a subacromial continuous ropivacaine infusion for post-operative pain management following arthroscopic rotator cuff surgery: a protocol for a randomised double-blind placebo-controlled trial. BMC Musculoskelet Disord 2008; 9: 56.
  153. Richards C, Andrews P, Spitz L, et al. Nissen fundoplication may induce gastric myoelectrical disturbance in children. J Pediatr Surg 1998; 33: 1801–1805.
  154. Burd RS, Price MR, Whalen TV. The role of protective antireflux procedures in neurologically impaired children: a decision analysis. J Pediatr Surg 2002; 37: 500–506.
  155. Vernon-Roberts A, Sullivan P. Fundoplication versus post-operative medication for gastro-oesophageal reflux in children with neurological impairment undergoing gastrostomy. Cochrane Database Syst Rev 2007; CD006151.
  156. Hassall E, Kerr W, El-Serag HB. Characteristics of children receiving proton pump inhibitors continuously for up to 11 years duration. J Pediatr 2007; 150: 262–267. e1.
  157. Hassall E, Israel D, Shepherd R, et al. Omeprazole for treatment of chronic erosive esophagitis in children: a multicenter study of efficacy, safety, tolerability and dose requirements. J Pediatr 2000; 137: 800–807.
  158. Gunasekaran TS, Hassall EG. Efficacy and safety of omeprazole for severe gastroesophageal reflux in children. J Pediatr 1993; 123: 148–154.
  159. Kawai M, Kawahara H, Hirayama S, et al. Effect of baclofen on emesis and 24-hour esophageal pH in neurologically impaired children with gastroesophageal reflux disease. J Pediatr Gastroenterol Nutr 2004; 38: 317–323.
  160. Wales PW, Diamond IR, Dutta S, et al. Fundoplication and gastrostomy versus image-guided gastrojejunal tube for enteral feeding in neurologically impaired children with gastroesophageal reflux. J Pediatr Surg 2002; 37: 407–412.
  161. Michaud L, Coopman S, Guimber D, et al. Percutaneous gastrojejunostomy in children: efficacy and safety. Arch Dis Child 2012; 97: 733–734.
  162. Pearl R, Robie D, Ein S, et al. Complications of gastroesophageal antireflux surgery in neurologically impaired versus neurologically normal children. J Pediatr Surg 1990; 25: 1169–1173.
  163. Goldin AB, Sawin R, Seidel KD, et al. Do antireflux operations decrease the rate of reflux-related hospitalizations in children? Pediatrics 2006; 118: 2326–2333.
  164. Blondeau K, Mertens V, Vanaudenaerde BA, et al. Nocturnal weakly acidic reflux promotes aspiration of bile acids in lung transplant recipients. J Heart Lung Transplant 2009; 28: 141–148.
  165. Smith C, Othersen Jr HB, Gogan NJ, et al. Nissen fundoplication in children with profound neurologic disability. High risks and unmet goals. Ann Surg 1992; 215: 654.
  166. Koivusalo A, Pakarinen MP, Rintala RJ. The cumulative incidence of significant gastrooesophageal reflux in patients with oesophageal atresia with a distal fistula--a systematic clinical, pH-metric, and endoscopic follow-up study. J Pediatr Surg 2007; 42: 370–374.
  167. Mathei J, Coosemans W, Nafteux P, et al. Laparoscopic Nissen fundoplication in infants and children: analysis of 106 consecutive patients with special emphasis in neurologically impaired vs. neurologically normal patients. Surg Endosc 2008; 22: 1054–1059.
  168. Esposito C, Van Der Zee D, Settimi A, et al. Risks and benefits of surgical management of gastroesophageal reflux in neurologically impaired children. Surgical Endoscopy and Other Interventional Techniques 2003; 17: 708–710.
  169. Kawahara H, Nakajima K, Yagi M, et al. Mechanisms responsible for recurrent gastroesophageal reflux in neurologically impaired children who underwent laparoscopic Nissen fundoplication. Surgical Endoscopy and Other Interventional Techniques 2002; 16: 767–771.
  170. Kawahara H, Okuyama H, Kubota A, et al. Can laparoscopic antireflux surgery improve the quality of life in children with neurologic and neuromuscular handicaps? J Pediatr Surg 2004; 39: 1761–1764.
  171. Lall A, Morabito A, Dall‘Oglio L, et al. Total oesophagogastric dissociation: experience in 2 centres. J Pediatr Surg 2006; 41: 342–346.
  172. Esposito C, Settimi A, Centonze A, et al. Laparoscopic-assisted jejunostomy. Surgical Endoscopy and Other Interventional Techniques 2005; 19: 501–504.
  173. Harding SM, Allen JE, Blumin JH, et al. Respiratory manifesta-tions of gastroesophageal reflux disease. Ann N Y Acad Sci 2013; 1300: 43–52.
  174. Scott RB, O‘Loughlin EV, Gall DG. Gastroesophageal reflux in patients with cystic fibrosis. J Pediatr 1985; 106: 223–227.
  175. Akinola E, Rosenkrantz TS, Pappagallo M, et al. Gastroesophageal reflux in infants <32 weeks gestational age at birth: lack of relationship to chronic lung disease. Am J Perinatol 2004; 21: 57–62.
  176. Chang AB, Glomb WB. Guidelines for evaluating chronic cough in pediatrics: ACCP evidence-based clinical practice guidelines. Chest 2006; 129: 260S–283S.
  177. Hershcovici T, Jha LK, Johnson T, et al. Systematic review: the relationship between interstitial lung diseases and gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2011; 34: 1295–305.

Neonatologie Pediatrie Praktické lékařství pro děti a dorost
Článek Editorial

Článek vyšel v časopise

Česko-slovenská pediatrie

Číslo 1

2016 Číslo 1

Nejčtenější v tomto čísle

Tomuto tématu se dále věnují…


Zvyšte si kvalifikaci online z pohodlí domova

Jistoty a nástrahy antikoagulační léčby aneb kardiolog - neurolog - farmakolog - nefrolog - právník diskutují
nový kurz
Autoři: doc. MUDr. Štěpán Havránek, Ph.D., prof. MUDr. Roman Herzig, Ph.D., doc. MUDr. Karel Urbánek, Ph.D., prim. MUDr. Jan Vachek, MUDr. et Mgr. Jolana Těšínová, Ph.D.

Léčba akutní pooperační bolesti
Autoři: doc. MUDr. Jiří Málek, CSc.

Nové antipsychotikum kariprazin v léčbě schizofrenie
Autoři: Prof. MUDr. Cyril Höschl, DrSc., FRCPsych.

Familiární transthyretinová periferní polyneuropatie
Autoři: MUDr. Radim Mazanec, Ph.D.

Diabetes mellitus a kardiovaskulární riziko, možnosti jeho ovlivnění

Všechny kurzy
Kurzy Doporučená témata Časopisy
Zapomenuté heslo

Nemáte účet?  Registrujte se

Zapomenuté heslo

Zadejte e-mailovou adresu se kterou jste vytvářel(a) účet, budou Vám na ni zaslány informace k nastavení nového hesla.


Nemáte účet?  Registrujte se